Red cell aplasia due to host type isohemagglutinins with exuberant red cell progenitor production of donor type in an ABO-mismatched allogeneic bone marrow transplant recipientCOCKERILL, K. J; LYDING, J; ZANDER, A. R et al.European journal of haematology. 1989, Vol 43, Num 3, pp 195-200, issn 0902-4441Article

Monitoring anti-thymocyte globulin (ATG) in bone marrow recipientsEIERMANN, T; LAMBRECHT, P; ZANDER, A. R et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 8, pp 779-781, issn 0268-3369Article

Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myelomaKRÖGER, N; ZABELINA, T; AYUK, F et al.Leukemia. 2011, Vol 25, Num 10, pp 1657-1661, issn 0887-6924, 5 p.Article

Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCTALCHALBY, H; BADBARAN, A; BOCK, O et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 9, pp 1404-1407, issn 0268-3369, 4 p.Article

Hämatopoetische Stammzelltransplantation vom Fremdspender bei Kindern: Niedrige Toxizität durch GvHD-Prophylaxe mit CSA, MTX, Metronidazol, iv-Immunglobulin und ATG = Unrelated donor stem cell transplantation in children: Low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole, iv-immunoglobulin and ATGFINCKENSTEIN, F. Graf; ZABELINA, T; DÜRKEN, M et al.Klinische Pädiatrie. 2002, Vol 214, Num 4, pp 206-211, issn 0300-8630Article

Busulfan, cyclophosphamide, and etoposide e as high-dose conditioning regimen in patients with malignant lymphomaHÄNEL, M; KRÖGER, N; HOFFKNECHT, M. M et al.Annals of hematology (Print). 2002, Vol 81, Num 2, pp 96-102, issn 0939-5555Article

A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndromeKRÖGER, N; SCHETELIG, J; ZABELINA, T et al.Bone marrow transplantation (Basingstoke). 2001, Vol 28, Num 7, pp 643-647, issn 0268-3369Article

Roquinimex (Linomide) vs placebo in AML after autologous bone marrow transplantationSIMONSSON, B; TOTTERMAN, T; MEIER, K et al.Bone marrow transplantation (Basingstoke). 2000, Vol 25, Num 11, pp 1121-1127, issn 0268-3369Article

Bicistronic retroviral vectors for combining myeloprotection with cell-surface markingHILDINGER, M; SCHILZ, A; ECKERT, H.-G et al.Gene therapy (Basingstoke). 1999, Vol 6, Num 7, pp 1222-1230, issn 0969-7128Article

Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancerKRÜGER, W; TÖGEL, F; KRÖGER, N et al.Medical oncology (Northwood). 1999, Vol 16, Num 1, pp 17-22, issn 1357-0560Article

Mobilizing peripheral blood stem cells with high-dose G-CSF alone is as effective as with Dexa-BEAM plus G-CSF in lymphoma patientsKRÖGER, N; ZELLER, W; FEHSE, N et al.British journal of haematology. 1998, Vol 102, Num 4, pp 1101-1106, issn 0007-1048Article

Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantationKOEHNE, G; ZELLER, W; STOCKSCHLAEDER, M et al.Bone marrow transplantation (Basingstoke). 1997, Vol 19, Num 2, pp 149-156, issn 0268-3369Article

Methylprednisolone, cyclosporine and methotrexate for prophylaxis of acute graft-versus-host diseaseYAU, J. C; LEMAISTRE, C. F; ZANDER, A. R et al.Bone marrow transplantation (Basingstoke). 1990, Vol 5, Num 4, pp 269-272, issn 0268-3369Article

Regeneration of T lymphocytes from human bone marrow cells after depletion with methylprednisoloneYAU, J. C; CHOW, H. S; KULKARNI, S. S et al.Journal of clinical & laboratory immunology. 1986, Vol 19, Num 1, pp 15-18, issn 0141-2760Article

High-dose cyclophosphamide, carmustine, and etoposide and autologous bone marrow transplantation for relapsed Hodgkin's diseaseJAGANNATH, S; DICKE, K. A; ARMITAGE, J. O et al.Annals of internal medicine. 1986, Vol 104, Num 2, pp 163-168, issn 0003-4819Article

Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapyZANDER, A. R; DICKE, K. A; RAJI AYYAR et al.Cancer. 1985, Vol 56, Num 6, pp 1374-1379, issn 0008-543XArticle

Direct ionization and electron capture in M-shell X-ray production by fluorine ionsMEHTA, R; DUGGAN, J. L; MCDANIEL, F. D et al.Physical review. A, General physics. 1983, Vol 28, Num 5, pp 2722-2726, issn 0556-2791Article

Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioningCASPER, J; HOLOWIECKI, J; BLAU, I et al.Bone marrow transplantation (Basingstoke). 2012, Vol 47, Num 9, pp 1171-1177, issn 0268-3369, 7 p.Article

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44⁺) and T (HLA-DR⁺) cellsLIOZNOV, M; EL-CHEIKH, J; FEHSE, B et al.Bone marrow transplantation (Basingstoke). 2010, Vol 45, Num 2, pp 349-353, issn 0268-3369, 5 p.Article

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning. CommentarySHIMONI, A; KRÖGER, N; NAGLER, A et al.Leukemia. 2005, Vol 19, Num 1, pp 7-12, issn 0887-6924, 9 p.Article

Low incidence of secondary myelodysplasia and acute myeloid leukemia after high-dose chemotherapy as adjuvant therapy for breast cancer patients: a study by the Solid Tumors Working Party of the European Group for Blood and Marrow TransplantationKRÖGER, N; ZANDER, A. R; MARTINELLI, G et al.Annals of oncology. 2003, Vol 14, Num 4, pp 554-558, issn 0923-7534, 5 p.Article

A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myelomaEINSELE, H; BAMBERG, M; KRÖGER, N et al.Bone marrow transplantation (Basingstoke). 2003, Vol 32, Num 6, pp 593-599, issn 0268-3369, 7 p.Article

Stem cell mobilisation with 16 μg/kg vs 10 μg/kg of G-CSF for allogeneic transplantation in healthy donorsKRÖGER, N; RENGES, H; SONNENBERG, S et al.Bone marrow transplantation (Basingstoke). 2002, Vol 29, Num 9, pp 727-730, issn 0268-3369Article

Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphomaHÄNEL, M; KRÖGER, N; FIEDLER, F et al.Journal of cancer research and clinical oncology. 2001, Vol 127, Num 6, pp 387-395, issn 0171-5216Article

Allogeneic bone marrow transplantation for refractory mantle cell lymphomaKRÖGER, N; HOFFKNECHT, M; KRÜGER, W et al.Annals of hematology (Print). 2000, Vol 79, Num 10, pp 578-580, issn 0939-5555Article